Vaccines for Respiratory Syncytial Virus Prevention in Older Adults

CONCLUSIONS: The RSVpreF3-ASO1E and RSVpreF vaccines effectively prevent RSV-associated LRTD in adults aged 60 years and older.PMID:38563554 | DOI:10.1177/10600280241241049

Source: The Annals of Pharmacotherapy - April 2, 2024 Category: Drugs & Pharmacology Authors: Daniel Wroblewski Lindsay A Brust-Sisti Matthew Bridgeman Mary Barna Bridgeman Source Type: research